Medicare Advantage: Rules On Formularies, PPOs Raise Concerns
Many questions remain before Medicare reform can be completed. As the Centers for Medicare & Medicaid Services works to finalize regulations for last year's Medicare Modernization Act, the most anxiety from lawmakers and stakeholder groups seems focused on drug-formulary issues, region size for preferred provider organizations, and employer subsidies for retiree drug coverage. Those were the top issues raised by witnesses and lawmakers from both parties at a Sept. 14 Senate Finance Committee hearing on the proposed rules, which were issued this summer.
What drugs are on formularies - and how to get those that aren't - will continue...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: